期刊文献+

宫腔镜下子宫内膜息肉摘除术后给予孕激素治疗对息肉复发的预防价值 被引量:4

Preventive Value of Progesterone Therapy after Hysteroscopic Endometrial Polypectomy on Polyp Recurrence
下载PDF
导出
摘要 目的探讨宫腔镜下子宫内膜息肉摘除术后给予孕激素治疗对息肉复发的预防价值。方法选取2016年6月至2017年6月于我院行宫腔镜下子宫内膜息肉摘除术的子宫内膜息肉患者56例,随机分为两组各28例。对照组行宫腔镜下子宫内膜息肉摘除术后不作任何处理,观察组在宫腔镜下子宫内膜息肉摘除术后给予复方醋酸环丙孕酮片治疗。比较两组患者治疗后的异常子宫出血、息肉复发情况及治疗前后的子宫内膜厚度。结果治疗6个月后,观察组异常子宫出血改善率为89.29%,高于对照组的64.29%(P <0.05);观察组的息肉复发率为3.57%,低于对照组的28.57%(P <0.05)。治疗前,两组患者的子宫内膜厚度比较差异无统计学意义(P>0.05);治疗6个月后,两组患者子宫内膜厚度比较差异有统计学意义(P <0.05)。结论宫腔镜下子宫内膜息肉摘除术后给予孕激素治疗能够有效改善患者的子宫出血情况,降低息肉复发率,改善子宫内膜厚度。 Objective To explore the preventive value of progesterone therapy after hysteroscopic endometrial polypectomy on polyp recurrence. Methods 56 cases of endometrial polyp patients undergoing hysteroscopic endometrial polypectomy in our hospital from June2016 to June 2017 were selected and randomly divided into two groups, with 28 cases in each group. The control group did not received any treatment after hysteroscopic endometrial polypectomy. The observation group was treated with compound cyproterone acetate tablets after hysteroscopic endometrial polypectomy. The abnormal uterine bleeding and polyp recurrence after treatment, and the endometrial thickness before and after treatment of the two groups were compared. Results 6 months after treatment, the improvement rate of abnormal uterine bleeding of the observation group was 89.29%, higher than 64.29% of the control group(P<0.05);The polyp recurrence rate of the observation group was 3.57%, lower than 28.57% of the control group(P<0.05). Before treatment, no statistical difference was found in the endometrial thickness between the two groups(P >0.05). 6 months after treatment, statistical difference was found in the endometrial thickness between the two groups(P<0.05). Conclusions Progesterone therapy after hysteroscopic endometrial polypectomy can effectively improve the uterine bleeding of patients, reduce the polyp recurrence rate and improve the endometrial thickness.
作者 陈泳华 周美娟 CHEN Yonghua;ZHOU Meijuan(Department of Obstetrics and Gynecology, Maternal and Child Health Hospital of Nardiai District, Foshan 528000, China)
出处 《临床医学工程》 2019年第5期587-588,共2页 Clinical Medicine & Engineering
关键词 宫腔镜下子宫内膜息肉摘除术 子宫内膜息肉 复方醋酸环丙孕酮片 Hysteroscopic endometrial polypectomy Endometrial polyps Compound cyproterone acetate tablets
  • 相关文献

参考文献8

二级参考文献78

  • 1宋爽,赵红.电视宫腔镜治疗异常子宫出血155例临床分析[J].中国妇幼保健,2006,21(4):477-478. 被引量:7
  • 2彭雪冰,夏恩兰.子宫内膜息肉中雌激素受体和孕激素受体的表达特点及意义[J].首都医科大学学报,2006,27(1):117-119. 被引量:29
  • 3贾建东,陈爱连.米非司酮治疗围绝经期功能失调性子宫出血56例临床观察[J].中国计划生育学杂志,2007,15(7):433-433. 被引量:6
  • 4[1]Kommoss F, Karck U, Prmpeler H, et al. Steroid receptor expression in endometria from women treated with tamoxifen[J]. Gynecologic oncology, 1998,70(2):188-191.
  • 5[2]Kim MR, Kim YA, Jo MY, et al. High frequency of endometrial polyps in endometriosis[J]. J Am Assoc Gynecol Laparosc, 2003,10(1):46-48.
  • 6[3]Savelli L, De Iaco P, Santini D, et al. Hystopathologic features and risk factors for benignity, hyperplasia, and cancer in endometrial polyps[J]. J Am Assoc Gynecol Laparosc,2003,188(4):927-931.
  • 7[4]Bouda J Jr, Hradecky L, Rokyta Z. Hysteroscopic polypectomy versus fractionated curettage in the treatment of corporal polyps-recurrence of corporal polyps[J]. Ceska Gynekol,2000,65(3):147-151.
  • 8[5]Mittal K, Schwartz L, Goswami S, et al. Estrogen and progesterone receptor expression in endometrial polyps[J]. Int J Gynecol Pathol,1996,15(4):345-348.
  • 9[6]Maia H, Maltez A, Athayde C, et al. Proliferation profile of endometrial polyps in post-menopausal women[J]. Maturitas,2001,40(3):273-281.
  • 10[7]Tallini G , Vanni R, Ianfioletti G, et al. HMGI-C and HMGI(Y) immunoreactivity correlates with cytogenetic abnormalities in lipomas,pulmonary chondroid hamartomas,endometrial polyps,and uterine leiomyomas and is compatible with rearrangement of the HMGI-C and HMGI(Y) genes[J]. Lab Invest,2000,80(1):359-369.

共引文献244

同被引文献33

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部